Asadi-Pooya AA, Borzoee M, Amoozgar H. The experience with 113 patients with Kawasaki disease in Fars Province, Iran. Turk J Pediatr. 2006; 48: 109–14.
Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA. Committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American heart association: diagnosis, treatment and long-term management in Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease in the young, American heart association. Pediatrics. 2004;114:1708–33.
Article
PubMed
Google Scholar
Shalhoub RJ. Pathogenesis of lipoid nephrosis: a disorder of T cell function. Lancet. 1979;7:556–60.
Krug P, Boyer O, Balzamo E, Sidi D, Lehnert A, Niaudet P. Nephrotic syndrome in Kawasaki disease: a report of three cases. Pediatr Nephrol. 2012;27:1547–50.
Article
PubMed
Google Scholar
Vivarelli M, Massella L, Ruggiero B, Emma F. Minimal change disease. Clin J Am Soc Nephrol. 2017;12:332–45.
Article
PubMed
Google Scholar
Sanchez-Niño MD, Bentio-Martin A, Gonoçalves S, Sanz AB, Ucero AC, Izquierdo MC, Ramos AM, Berzal S, Selgas R, Ruiz-Ortega M, Egido J, Ortis A. TNF superfamily: a growing saga of kidney injury modulators. Mediat Inflamm. https://doi.org/10.1055/2010/182958.
Brähler S, Ising C, Aranda BB, Höhne M, Schermer B, Benzing T, Brinkkoetter PT. The NF-κB essential modulator (NEMO) controls podocyte cytoskeletal dynamics independently of NF-κB. Am J Physiol Renal Physiol. 2015;309:617–26.
Article
Google Scholar
Brogan PA, Bose A, Burgner D, Shingadia D, Tulloh R, Michie C, Klein N, Booy R, Levin M, Dillon MJ. Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child. 2002;86:286–90.
CAS
Article
PubMed
PubMed Central
Google Scholar
Nardi PM, Haller JO, Friedman AP, Slovis TL, Schaffer RM. Renal manifestations of Kawasaki’s disease. Pediatr Radiol. 1985;15:116–8.
CAS
Article
PubMed
Google Scholar
Watanabe T, Abe Y, Sato S, Uehara Y, Ikeno K, Abe T. sterile pyuria in patients with Kawasaki disease originates from both the urethra and the kidney. Pediatr Nephrol. 2007;22:987–91.
Article
PubMed
Google Scholar
Maji B, Banerjee S, Pal P. Nephrotic syndrome in Kawasaki disease. Clin Pediatr. 2014;53(9):898–9.
Article
Google Scholar
Leung DY, Geha RS, Newburger JW, Burns JC, Fiers W, Lapierre LA, Pober JS. Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J Exp Med. 1986;164(6):1958–72.
CAS
Article
PubMed
Google Scholar
Kidney Disease Improving Global Outcomes Glomerulonephritis Work Group. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int 2(Suppl. 2):163–71.
Suzuki N, Seguchi M, Kouno C, Inukai K, Kito H, Kobayashi H. Rupture of coronary aneurysm in Kawasaki disease. Pediatr Int. 1999;41:318–20.
CAS
Article
PubMed
Google Scholar
Kobayashi T, IInoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, Kobayashi T, Morikawa A. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006;113:2606–12.
Article
PubMed
Google Scholar
Lee J, Kim GB, Kwon BS, Bae EJ, Noh CI. Two cases of super-giant coronary aneurysms after Kawasaki disease. Korean Circ J. 2014;44:54–8.
Article
PubMed
PubMed Central
Google Scholar